The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent thei ...

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation ...

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, accordi ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disabilit ...

Multimorbidity is strongly associated with accelerated kidney function decline in older age, according to a study pu ...

The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research l ...

For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of ...

Specific anaphylactic triggers are associated with symptoms and treatments, according to a study published online No ...

Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according t ...

Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcome ...

THURSDAY, Dec. 26, 2024 (HealthDay News) -- A brief outpatient rehabilitation program with a cognitive and behavioral ...